ArticleMolecular neurobiology2026
Hippocampal Bioenergetics and Metabolic Profiling Identifies Fatty Acid Oxidation as a Potential Therapeutic Target in Traumatic Brain Injury.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Traumatic brain injury (TBI) causes lasting neurological impairments, particularly learning and memory deficits associated with hippocampal damage. Emerging evidence suggests that hippocampal vulnerability may be linked to bioenergetic dysfunction, though its role remains poorly defined. A deeper understanding of post-TBI metabolic disturbances and their association with pathological outcomes could reveal novel therapeutic targets. In this study, we conducted functional bioenergetic assessments and multi-omics analyses on hippocampal slices using a mouse controlled cortical impact model of TBI. Seahorse analysis revealed a significant reduction in mitochondrial oxidative phosphorylation in dentate gyrus (DG) slices at day 1 (acute phase), which recovered by day 7 (subacute phase) post-TBI. Metabolomic profiling revealed acute impairments in purine nucleotide, glucose, amino acid, and fatty acid metabolism, most of which normalized by day 7. Isotope tracing indicated enhanced octanoate-derived fatty acid oxidation (FAO) in DG slices at day 7 post-TBI. Proteomics confirmed suppressed purine metabolism at day 1 across hippocampal subregions, while FAO remained preserved at day 1 and became significantly elevated by day 7, suggesting a compensatory metabolic adaptation. Administration of sodium octanoate, a medium-chain fatty acid, at 1 h post-TBI enhanced mitochondrial respiration at 24 h, reduced microglial counts at 48 h, and attenuated neurodegeneration by day 3. These findings identify FAO enhancement as a promising metabolic strategy to restore hippocampal bioenergetics and promote neuroprotection following TBI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.